1. Home
  2. BTG vs APLS Comparison

BTG vs APLS Comparison

Compare BTG & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTG
  • APLS
  • Stock Information
  • Founded
  • BTG 2006
  • APLS 2009
  • Country
  • BTG Canada
  • APLS United States
  • Employees
  • BTG N/A
  • APLS N/A
  • Industry
  • BTG Precious Metals
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BTG Basic Materials
  • APLS Health Care
  • Exchange
  • BTG Nasdaq
  • APLS Nasdaq
  • Market Cap
  • BTG 4.2B
  • APLS 4.0B
  • IPO Year
  • BTG N/A
  • APLS 2017
  • Fundamental
  • Price
  • BTG $2.39
  • APLS $29.94
  • Analyst Decision
  • BTG Buy
  • APLS Buy
  • Analyst Count
  • BTG 3
  • APLS 18
  • Target Price
  • BTG $4.02
  • APLS $46.59
  • AVG Volume (30 Days)
  • BTG 15.1M
  • APLS 2.1M
  • Earning Date
  • BTG 02-19-2025
  • APLS 02-25-2025
  • Dividend Yield
  • BTG 5.02%
  • APLS N/A
  • EPS Growth
  • BTG N/A
  • APLS N/A
  • EPS
  • BTG N/A
  • APLS N/A
  • Revenue
  • BTG $1,914,216,000.00
  • APLS $715,216,000.00
  • Revenue This Year
  • BTG $2.67
  • APLS $95.82
  • Revenue Next Year
  • BTG $41.99
  • APLS $12.02
  • P/E Ratio
  • BTG N/A
  • APLS N/A
  • Revenue Growth
  • BTG N/A
  • APLS 162.10
  • 52 Week Low
  • BTG $2.32
  • APLS $24.34
  • 52 Week High
  • BTG $3.50
  • APLS $71.90
  • Technical
  • Relative Strength Index (RSI)
  • BTG 36.50
  • APLS 43.96
  • Support Level
  • BTG $2.34
  • APLS $27.61
  • Resistance Level
  • BTG $2.53
  • APLS $30.13
  • Average True Range (ATR)
  • BTG 0.09
  • APLS 1.48
  • MACD
  • BTG -0.00
  • APLS -0.46
  • Stochastic Oscillator
  • BTG 19.44
  • APLS 31.45

About BTG B2Gold Corp Common shares (Canada)

B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other significant assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into a global market. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: